These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2465218)

  • 41. [Dynamic investigation of antithrombin III in the plasma of patients with acute myocardial infarction].
    Zhu JZ; Chen SL; Cui ZC
    Zhonghua Nei Ke Za Zhi; 1991 Dec; 30(12):746-8, 789. PubMed ID: 1815877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antithrombin III level in patients with acute viral myocarditis].
    Doroshenko BH
    Lik Sprava; 2003; (3-4):63-5. PubMed ID: 12889361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antithrombin III in patients on long-term oral anticoagulants.
    Bull H; Mackie I; Brozović M; Woodings D
    J Clin Pathol; 1980 Dec; 33(12):1202-5. PubMed ID: 7451667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylaxis of thrombosis in antithrombin III-deficient women during pregnancy and delivery.
    Michiels JJ; Stibbe J; Vellenga E; van Vliet HH
    Eur J Obstet Gynecol Reprod Biol; 1984 Oct; 18(3):149-53. PubMed ID: 6500155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevention of the thromboembolic risk during the operative period in a patient with a congenital antithrombin III deficiency].
    Franceschi A; Testard J; Borg JY; Papion H; Ducable G; Saour N; Winckler C
    Ann Fr Anesth Reanim; 1983; 2(6):420-2. PubMed ID: 6660606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiency.
    Tengborn L; Frohm B; Nilsson LE; Nilsson IM
    Scand J Clin Lab Invest; 1981 Sep; 41(5):469-77. PubMed ID: 7031840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolonged oral contraceptive therapy in a woman with an antithrombin III abnormality involving heparin binding (type IIc) without thromboembolic complications.
    Girolami A; Zanardi S; Simioni P; Tormene D
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):313-4. PubMed ID: 8054465
    [No Abstract]   [Full Text] [Related]  

  • 48. Purified radiolabeled antithrombin III metabolism in three families with hereditary AT III deficiency: application of a three-compartment model.
    Knot EA; de Jong E; ten Cate JW; Iburg AH; Henny CP; Bruin T; Stibbe J
    Blood; 1986 Jan; 67(1):93-8. PubMed ID: 3940555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proceedings: The significance of the chronic anticoagulant treatment in recurrent thromboembolie caused by hereditary antithrombin III deficiency.
    Nagy I; Losonczy H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):366. PubMed ID: 1188835
    [No Abstract]   [Full Text] [Related]  

  • 50. [Anticoagulant activity of endothelial cells. A role of heparinlike compounds].
    Shimada K
    Rinsho Byori; 1990 Jul; Suppl 86():116-23. PubMed ID: 1700172
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of anticoagulant therapy on antithrombin III levels.
    Sirridge MS; Shannon R; Hardin WM
    J Am Med Womens Assoc (1972); 1982 Aug; 37(8):216-20. PubMed ID: 7130599
    [No Abstract]   [Full Text] [Related]  

  • 52. Potential Effects of Carbamylation on Protein S, Protein C, and Antithrombin III.
    Neves YSD; Carvalho JAM; Pereira KN; Moresco RN
    Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345988
    [No Abstract]   [Full Text] [Related]  

  • 53. Oral anticoagulation and antithrombin III.
    Love E; Taberner D; Easton A
    J Clin Pathol; 1981 Sep; 34(9):1065. PubMed ID: 7276219
    [No Abstract]   [Full Text] [Related]  

  • 54. Antithrombin III as predictor of liver reserve: A new parameter to improve the results of mechanical circulatory support therapy.
    Di Giammarco G; Marinelli D
    J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1383. PubMed ID: 28365010
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of a chromogenic antithrombin III assay using a fixed band spectrophotometer.
    Andreasen CB; Lovelady S
    Vet Clin Pathol; 1993; 22(2):42-44. PubMed ID: 12669277
    [No Abstract]   [Full Text] [Related]  

  • 56. Changes of antithrombin III (AT III) in AT III deficient patients during long-term anticoagulant treatment.
    Nagy I; Losonczy H; Temesi C; Pálmai V; Storcz E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):292-6. PubMed ID: 2465218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inherited antithrombin III deficiency and cerebral thrombosis in a child.
    Ambruso DR; Jacobson LJ; Hathaway WE
    Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusing.
    Leone G; De Stefano V; Ferrelli R; Teofili L; Tengborn L; Vahtera E; Bizzi B
    Thromb Haemost; 1988 Aug; 60(1):8-12. PubMed ID: 3187949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
    Rodgers GM
    Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antithrombin III deficiency: clinical aspects.
    Nagy I
    Haematologia (Budap); 1984; 17(1):87-91. PubMed ID: 6724356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.